Clinigen, Mitsubishi link for early access programme

23rd May 2018 Uncategorised 0

Clinigen says it has partnered with Mitsubishi Tanabe Pharma to initiate a Managed Access Program in Europe for edaravone, an intravenous treatment for amyotrophic lateral sclerosis (ALS).

More: Clinigen, Mitsubishi link for early access programme
Source: News